Illumina Mulls FDA Clearance of HiSeq 2000; Sees Strong Demand for Whole-Genome Sequencing

An Illumina official said hat the HiSeq 2000 has already lowered the cost of human genome sequencing to $10,000 or less, "and over the near term, or near-mid term, we should be able to get to the $1,000 genome with this kind of technology."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.